Browse our wide selection of products for your research needs
We can offer a discount on bulk orders.
Please contact our sales team for further inquiry.
| Product Name | Doxorubicin-self-assembled micelles loaded on lipid nanoparticles and coupled with PTP peptide and diethylenetriaminepentaacetic acid |
| Catalog Number | LNP-136 |
| Size | 10 mg; 20 mg; 50 mg |
| Alias | DOX-SAA@LNP-PTP-DTPA; DOX-SAA@LNP-PTP peptide-DTPA |
| Appearance | Dispersion |
| Solubility | It can be stably dispersed in aqueous solution to form a colloidal system |
| Description | DOX-SAA@LNP-PTP peptide-DTPA is a multifunctional nanodrug delivery system integrating drug loading, targeted delivery, and imaging functions. Doxorubicin (DOX), as the core anti-tumor drug, can effectively inhibit tumor cell proliferation; The composite carrier formed by self-assembled micelles (SAA)and lipid nanoparticles (LNP)has good biocompatibility and high drug-loading capacity. It can encapsulate doxorubicin, prolong the time the drug circulates in the body, and reduce the early release of the drug and the side effects on normal tissues. |
| Applications | Drug delivery system |
| Storage | 2-8°C, protected from light |
| Purity | 95%+ |
| Shelf Life | 1 Year |
| Shipping Condition | Low temperature transport |